Related references
Note: Only part of the references are listed.Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics
Jonathan A. Robbins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Rifampicin induces the bone form of alkaline phosphatase in humans
Heba Nabil et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)
Pregnane X Receptor-4β-Hydroxycholesterol Axis in the Regulation of Overweight- and Obesity-Induced Hypertension
Roosa Rahunen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
BCPT policy for experimental and clinical studies
Pernille Tveden-Nyborg et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)
Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2-mediated mechanism
Mikko Karpale et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity
Fatemeh Hassani-Nezhad-Gashti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters
Tuire Salonurmi et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis
Christopher Trent Brewer et al.
TOXICOLOGICAL SCIENCES (2019)
Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition
Hong Shen et al.
DRUG METABOLISM AND DISPOSITION (2018)
Quantitative analysis of 4β- and 4α-hydroxycholesterol in human plasma and serum by UHPLC/ESI-HR-MS
Heidi Hautajarvi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
PXR: More Than Just a Master Xenobiotic Receptor
Peter O. Oladimeji et al.
MOLECULAR PHARMACOLOGY (2017)
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay
Ravindranath Reddy Gilibili et al.
DRUG METABOLISM AND DISPOSITION (2017)
Inherited disorders of bilirubin clearance
Naureen Memon et al.
PEDIATRIC RESEARCH (2016)
Regulation of hepatic energy metabolism by the nuclear receptor PXR
Jukka Hakkola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes
Benjamin A. Kandel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver
Madhav Sachar et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes
Eric A. Benson et al.
FRONTIERS IN PHARMACOLOGY (2016)
Protoporphyrin IX: the Good, the Bad, and the Ugly
Madhav Sachar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition
Yurong Lai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Heme and erythropoieis: more than a structural role
Deborah Chiabrando et al.
HAEMATOLOGICA (2014)
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy
Feng Li et al.
NATURE MEDICINE (2013)
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
Chibueze A. Ihunnah et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Urinary Elimination of Coproporphyrins Is Dependent on ABCC2 Polymorphisms and Represents a Potential Biomarker of MRP2 Activity in Humans
Isabelle Benz-de Bretagne et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action
Mateja Hafner et al.
PHARMACOGENETICS AND GENOMICS (2011)
Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver
Ikumi Chisaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients
Maarten Naesens et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Transcriptional regulation of human UGT1A1 gene expression:: Activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1
J Sugatani et al.
MOLECULAR PHARMACOLOGY (2005)
Identification of the xenosensors regulating human 5-aminolevulinate synthase
M Podvinec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene
DJ Fraser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor
HR Kast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
A Geick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
